Tumor treating fields in malignant pleural mesothelioma: from cytoskeletal collapse to immunophenotypic conversion

August 19, 2026 | Comments Off on Tumor treating fields in malignant pleural mesothelioma: from cytoskeletal collapse to immunophenotypic conversion

Frontiers in Oncology 2026 May 26 [Link] Xiaofeng Ma, Zhuo Zuo, Yulong Sun, Hong An Abstract The therapeutic efficacy in malignant pleural mesothelioma (MPM) is severely hindered by its dense…

Ki67 proliferation index augments two-tier tumour grade in prediction of survival and progression-free survival in epithelioid pleural mesothelioma

August 18, 2026 | Comments Off on Ki67 proliferation index augments two-tier tumour grade in prediction of survival and progression-free survival in epithelioid pleural mesothelioma

ERJ Open Research 2026 June 8 [Link] Geraldine A Lynch, Yu Zhi Zhang, Nidhi Bhatt, Pia Charters, Avinash Aujayeb, Saru Walker, Jenny Symonds, Amelia O Clive, Rahul Bhatnagar, Anna Morley,…

The Role of EZH2 ın Malıgnant Pleural Mesothelıoma and Beyond: Current Practıce and Future Perspectıves

August 17, 2026 | Comments Off on The Role of EZH2 ın Malıgnant Pleural Mesothelıoma and Beyond: Current Practıce and Future Perspectıves

Current Oncology Reports 2026 June 8 [Link] Mehmet Kucukoner, Tarik Demir, Abduljalil Mohammed Alsubaie, Ulas Alabalik, Aisha K Ibrahim, Mariaelena Pierobon, Lance Liotta Abstract Purpose of review: Malignant pleural mesothelioma…

Protein phosphatase 2 phosphatase activator (PTPA) promotes oncogene-induced senescence and carboplatin response in human malignant pleural mesothelioma cells

August 14, 2026 | Comments Off on Protein phosphatase 2 phosphatase activator (PTPA) promotes oncogene-induced senescence and carboplatin response in human malignant pleural mesothelioma cells

Cellular Oncology 2026 June 8 [Link] Eleonora Nigliato, Yan Ma, Rita Derua, Maria Butyrin, Sandra P Nunes, Léa Guilmot, Antonio De Gianni, Rüveyda Dok, Andrew P Feld, Michael Ohlmeyer, Brian…

A single-center experience in parenchyma-sparing surgical treatment of malignant pleural mesothelioma

August 13, 2026 | Comments Off on A single-center experience in parenchyma-sparing surgical treatment of malignant pleural mesothelioma

Updates in Surgery 2026 June 1 [Link] Giuseppe Mangiameli, Debora Brascia, Emanuela Re Cecconi, Veronica Maria Giudici, Edoardo Bottoni, Alessandro Crepaldi, Umberto Cariboni, Alberto Testori, Paolo Zucali, Matteo Perrino, Nadia…

Conditional survival patterns and individualized prognostic prediction in malignant peritoneal mesothelioma

August 12, 2026 | Comments Off on Conditional survival patterns and individualized prognostic prediction in malignant peritoneal mesothelioma

Scientific Reports 2026 June 1 [Link] Xiaofeng Liao, Chen Li, Ming Huang, Zheng Yao, Shikun Luo, Xiaoyu Lei Abstract Malignant peritoneal mesothelioma (MPM) is a rare, aggressive cancer with limited…

Localised malignant mesothelioma presenting as an esophageal mass: An unusual manifestation

August 11, 2026 | Comments Off on Localised malignant mesothelioma presenting as an esophageal mass: An unusual manifestation

Radiology Case Reports 2026 May 19 [Link] Kaspar L Yaxley, Tristan Rutland, Thisuri Jayawardena, David Law, Yuranga Weerakkody Abstract Malignant mesothelioma is an aggressive neoplasm arising from mesothelial cells, typically…

Feasibility and Outcomes of Cytoreductive Surgery and Hyperthermic Intrathoracic Chemoperfusion for Pleural Mesothelioma

August 10, 2026 | Comments Off on Feasibility and Outcomes of Cytoreductive Surgery and Hyperthermic Intrathoracic Chemoperfusion for Pleural Mesothelioma

The Annals of Thoracic Surgery 2026 May 28 [Link] Yota Suzuki, Inderpal S Sarkaria, Edra Ha, Ian G Christie, Olugbenga T Okusanya, Omar Awais, Evan T Alicuben, Ryan M Levy,…

A High-Fidelity Patient-Derived Organoid Platform Recapitulates the Dynamic Metabolic Landscape of Cisplatin Tolerance in Mesothelioma

August 7, 2026 | Comments Off on A High-Fidelity Patient-Derived Organoid Platform Recapitulates the Dynamic Metabolic Landscape of Cisplatin Tolerance in Mesothelioma

Cancers 2026 May 7 [Link] Zivile Useckaite, Ashleigh J Hocking, Lauren A Mortimer, John Salamon, Simon Lee, Yazad Irani, Lucy Franzon, Arya L Arul, Sarita Prabhakaran, Sonja Klebe Abstract Background:…

Quercetin-Arctigenin Co-Treatment Induces Mitochondrial Dysfunction and Apoptotic Cell Death Through Metabolic Stress in Malignant Mesothelioma Cells

August 6, 2026 | Comments Off on Quercetin-Arctigenin Co-Treatment Induces Mitochondrial Dysfunction and Apoptotic Cell Death Through Metabolic Stress in Malignant Mesothelioma Cells

Life 2026 May 6 [Link] Moon-Kyun Cho, Sang-Han Lee, Hae-Seon Nam, Yoon-Jin Lee Abstract Malignant mesothelioma is an aggressive cancer with limited therapeutic options, highlighting the need for novel strategies…

Categories